Annual Decline in Pentraxin 3 Is a Risk of Vascular Access Troubles in Hemodialysis Patients

Pentraxin 3 (PTX3), a multifunctional modulator of the innate immunoinflammatory response, is higher in patients undergoing hemodialysis than healthy control. Our study focused on annual change in PTX3 levels in patients with chronic hemodialysis, because regularly undergoing hemodialysis for many y...

Full description

Saved in:
Bibliographic Details
Main Authors: Kei Nagai, Atsushi Ueda, Chie Saito, Asako Zempo-Miyaki, Kunihiro Yamagata
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2014/297954
Tags: Add Tag
No Tags, Be the first to tag this record!